Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference

Rhea-AI Summary

Boston Scientific (NYSE: BSX) has announced its participation in TD Cowen's 45th Annual Health Care Conference scheduled for March 4, 2025. The company will be represented by three key executives: Dan Brennan (Executive VP and CFO), Art Butcher (Executive VP and Group President, MedSurg and Asia Pacific), and Dr. Kenneth Stein (Senior VP and Chief Medical Officer).

The executives will engage in a 30-minute fireside chat with the host analyst, beginning at approximately 9:10 a.m. ET. The session will be available via live webcast, with a replay accessible on the company's investor relations website approximately one hour after the event concludes.

News Market Reaction – BSX

+0.30%

+0.30% Session move

In the trading session that priced this news, BSX gained 0.30%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MARLBOROUGH, Mass., Feb. 19, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 45^th Annual Health Care Conference on Tuesday, March 4, 2025.

Dan Brennan, executive vice president and chief financial officer, Art Butcher, executive vice president and group president, MedSurg and Asia Pacific, and Kenneth Stein, M.D., senior vice president and chief medical officer, will participate in a 30-minute fireside chat with the host analyst at approximately 9:10 a.m. ET. A live webcast and replay of the session will be accessible at htts://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X, formerly Twitter.  

CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com

Jon Monson
Investor Relations
+1 (508) 683-5450
BSXInvestorRelations@bsci.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-td-cowens-45th-annual-health-care-conference-302378128.html

SOURCE Boston Scientific Corporation

FAQ

When is Boston Scientific (BSX) presenting at TD Cowen's Healthcare Conference 2025?

Boston Scientific will present at TD Cowen's Healthcare Conference on Tuesday, March 4, 2025, at approximately 9:10 a.m. ET.

Which Boston Scientific (BSX) executives are participating in TD Cowen's 2025 Healthcare Conference?

Dan Brennan (EVP & CFO), Art Butcher (EVP & Group President, MedSurg and Asia Pacific), and Dr. Kenneth Stein (SVP & Chief Medical Officer) will participate in the conference.

How long will Boston Scientific's (BSX) presentation be at the TD Cowen Healthcare Conference?

The presentation will be a 30-minute fireside chat with the host analyst.

How can investors access Boston Scientific's (BSX) TD Cowen Conference presentation?

Investors can access the presentation through a live webcast on Boston Scientific's investor relations website, with a replay available approximately one hour after the event.